TPMG Clinical Research Division is Looking for Eligible Patients for COVID-19 Investigational Treatment Trial
TPMG Clinical Research Division is Looking for Eligible Patients for COVID-19 Investigational Treatment Trial
Have you recently been diagnosed with COVID-19, or are you experiencing symptoms such as a fever, shortness of breath, cough, loss of taste, or have had known exposure to COVID-19?
If so, you may be eligible for a new COVID-19 investigational treatment trial.
The TPMG Clinical Research Division in Williamsburg, Virginia is conducting an outpatient investigational treatment trial for patients recently diagnosed with the novel coronavirus.
Participation Criteria
- Recent positive diagnosis and within 72 hour time frame of being notified
- Experiencing COVID-19 Related Symptoms – fever, cough, shortness of breath, loss of taste or smell
- Participation includes documenting experience in a digital diary
- Short Duration Study
- Participants will be compensated for their time